Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
|Articles|May 26, 2022
NCCHC Foundation Offers Scholarships for the NCCHC Correctional Mental Health Care Conference
Apply for a scholarship for the NCCHC Correctional Mental Health Care Conference!
Advertisement
The NCCHC Foundation will award scholarships for students and correctional health professionals who have three or less years of experience in the field to attend the NCCHC
The Scholarships will cover the full price of conference registration, a value of $425, plus travel and hotel expenses. Gifts are made possible by Centurion Health, Corizon Health, and other generous donors to the NCCHC Foundation.
Apply
Advertisement
Related to this article
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Experts highlight biomarker-driven schizophrenia care—computational subtypes, muscarinic drugs, sharper negative-symptom scoring, and KCC2 targets—reducing trial-and-error prescribing.
Panelists explain why precision tools lag in schizophrenia care and highlight simple biomarkers, faster deals, and clinician-industry collaboration.
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Clinicians Need to Know About Postpartum Psychosis
2
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
3
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
4
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
5